2seventy bio Inc (TSVT)
4.60
+0.03
(+0.66%)
USD |
NASDAQ |
May 01, 16:00
4.60
0.00 (0.00%)
After-Hours: 18:19
2seventy bio Gross Profit (Quarterly): 7.537M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.537M |
September 30, 2023 | 7.075M |
June 30, 2023 | 31.53M |
March 31, 2023 | 37.33M |
December 31, 2022 | 51.68M |
September 30, 2022 | 9.447M |
June 30, 2022 | 4.946M |
Date | Value |
---|---|
March 31, 2022 | -0.80M |
December 31, 2021 | 6.308M |
September 30, 2021 | 18.94M |
June 30, 2021 | -2.83M |
March 31, 2021 | 10.20M |
December 31, 2020 | 8.406M |
September 30, 2020 | 17.12M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-2.83M
Minimum
Jun 2021
51.68M
Maximum
Dec 2022
14.78M
Average
8.926M
Median
Gross Profit (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 8.933B |
Johnson & Johnson | 14.87B |
Regeneron Pharmaceuticals Inc | 2.917B |
Macrogenics Inc | 9.001M |
Akebia Therapeutics Inc | 37.53M |